Form 4: CTO Alavi Surrenders 50,000 Unvested NVNO RSUs

enVVeno Medical Corp's Chief Technology Officer, Hamed Alavi, has surrendered 50,000 unvested Restricted Stock Units due to unachieved performance milestones.

Summary

• Hamed Alavi, Chief Technology Officer of enVVeno Medical Corp (NVNO), reported a change in beneficial ownership.
• Alavi surrendered and canceled 50,000 Restricted Stock Units (RSUs) on December 16, 2025.
• The RSUs were originally issued on November 30, 2021, pursuant to the Issuer's Amended and Restated 2016 Omnibus Incentive Plan and a Restricted Stock Unit Agreement.
• The surrender occurred because specified performance milestones, which were conditions for vesting, were not achieved.

Sentiment

Score: 3

Explanation: The surrender of 50,000 Restricted Stock Units by the CTO due to unachieved performance milestones indicates a failure to meet specific targets, which is a negative signal regarding executive performance incentives and potentially broader company performance.

Negatives

• Chief Technology Officer Hamed Alavi surrendered 50,000 Restricted Stock Units.
• The surrender was due to the non-achievement of specified performance milestones, indicating that certain company or individual performance targets were not met.

Risks

• Non-achievement of performance milestones for executive compensation may signal challenges in meeting strategic objectives or operational targets.
• Potential impact on executive morale or retention if incentive compensation is not realized due to unachieved targets.

Future Outlook

The filing does not contain explicit forward-looking statements or guidance regarding the company's future performance or strategic direction.

Management Comments

• Hamed Alavi voluntarily agreed to surrender and cancel the unvested Restricted Stock Units due to the non-achievement of specified performance milestones.

Industry Context

This insider transaction, involving the surrender of performance-based executive compensation, is a specific event related to individual performance and company-set milestones rather than broader industry trends. Performance-based compensation is a standard practice across industries to align executive incentives with company goals.

Stakeholder Impact

• Shareholders: May view the non-achievement of performance milestones negatively, potentially impacting confidence in management's ability to meet strategic or operational targets.
• Employees: Could impact morale if executive incentives are not realized, potentially signaling broader performance issues within the company.

Key Dates

Recommendation

The surrender of 50,000 Restricted Stock Units by the Chief Technology Officer due to the non-achievement of specified performance milestones is a clear negative indicator. This suggests that key operational or strategic targets tied to executive incentives were not met, which could signal underlying challenges for enVVeno Medical Corp. Investors should consider this as a potential red flag regarding the company's ability to execute its plans and achieve its objectives, warranting a 'sell' recommendation.

Keywords

enVVeno Medical Corp, NVNO, Hamed Alavi, Chief Technology Officer, Restricted Stock Units, RSUs, executive compensation, performance milestones, insider transaction, Form 4, beneficial ownership